Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

123.71 -2.72 (-2.15%)
Official Closing Price Updated: 8:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Can Healthcare Stocks Survive Macro Headwinds? ↗
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
News headline image
Want Diversified Upside in Biotechnology? Check out LABU
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. 
Via MarketBeat
Topics ETFs Stocks
News headline image
US Judge Weighs Nationwide Ban On Abortion Pills ↗
U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is... 
Via Benzinga
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Biotech Stocks And The SVB Collapse — Here's What We Know ↗
The collapse of SVB will have a big impact on early-stage, venture-backed companies. 
Via Investor's Business Daily
News headline image
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well ↗
The Federal Deposit Insurance Corporation (FDIC) closed Silicon Valley Bank, the banking arm of SVB Financial Group (NASDAQ: 
Via Benzinga
News headline image
Small Cap Biotechs Slammed By SVB Collapse ↗
Nothing like a banking crisis to start off a weekend. But maybe by the end of this upcoming week of turmoil we'll worry less about inflation. 
Via Talk Markets
News headline image
6 Stock Market Thoughts For The Week Of March 13 ↗
A flight to safety seemed to be at play this week, with the market seeking safety first and asking questions later. This is not unusual, and once the situation is resolved, much of the decline in rates... 
Via Talk Markets
News headline image
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs ↗
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per... 
Via Benzinga
News headline image
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities ↗
 
Via Benzinga
News headline image
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading ↗
Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD. 
Via Talk Markets
News headline image
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
 
Via Benzinga
News headline image
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
News headline image
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the  SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, 
Via Benzinga
News headline image
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
News headline image
2 ETFs That Can Set You Up for Life ↗
Simplifying your investment strategy can help minimize your risk while still allowing you to earn some great returns. 
Via The Motley Fool
News headline image
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
News headline image
The Fed Should Stop Right Now ↗
A pause to refresh or a mild pullback would be good for the stock market after running hot and heavy. On Wednesday, we saw weaker economic data in retail sales. Unlike previous soft data, the stock... 
Via Talk Markets
News headline image
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. 
Via Talk Markets
News headline image
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing” ↗
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
News headline image
3 Unstoppable ETFs to Stock Up On in 2023 ↗
These ETFs could be big winners in the new year. 
Via The Motley Fool
News headline image
ETFs To Buy For 2023 After S&P 500's Worst Year Since 2008 ↗
The S&P 500 has dropped 19.4% in 2022. It marked the largest calendar-year decline since a 38% plunge in Lehman Bother’s crisis-laden 2008. Goldman Sachs, Bank of America and JPMorgan predict a U.S.... 
Via Talk Markets
News headline image
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
News headline image
5 Top Stocks for January ↗
Now is the time to begin crafting your watch list for 2023. 
Via The Motley Fool
News headline image
The Year In Review And Ahead ↗
We‘ll continue witnessing cost-push inflation combined with tight labor market – and it would be crude oil‘s time again to gain in value from current levels. 
Via Talk Markets
News headline image
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗
Biopharma stocks were not immune to the broader market downturn seen for much of 2022. 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy for the Long Haul ↗
These mid-cap biotechs are solid long-term choices. 
Via The Motley Fool
News headline image
Tuesday Talk: Where is Santa? ↗
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found. 
Via Talk Markets
News headline image
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro ↗
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning. 
Via Talk Markets
News headline image
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.